Exacerbation of oxygen-glucose deprivation-induced blood brain barrier disruption: potential pathogenic role of interleukin 9 in ischemic stroke

Interleukin (IL) -9 exerts a variety of functions in autoimmune diseases. However, its role in ischemic brain injury remains unknown. The present study explored the biological effects of IL-9 in ischemic stroke. We recruited 42 patients newly diagnosed with ischemic stroke and 22 age- and sex-matched healthy controls. The expression levels of IL-9 and percentages of IL-9-producing T cells, including CD3+CD4+IL-9+ and CD3+CD8+IL-9+ cells, were determined in peripheral blood mononuclear cells (PBMCs) obtained from patients and control individuals. We also investigated the effects of IL-9 on the blood brain barrier (BBB) following oxygen-glucose deprivation and the potential downstream signaling pathways. We found that patients with ischemic stroke had higher IL-9 expression levels and increased percentages of IL-9-producing T cells in their PBMCs. The percentages of CD3+CD4+IL-9+ and CD3+CD8+IL-9+ T cells were positively correlated with the severity of illness. In invitro experiments using bEnd.3 cells, exogenously administered IL-9 exacerbated the loss of tight junction proteins in cells subjected to oxygen-glucose deprivation plus reoxygenation. This effect was mediated via activation of IL-9 receptors, which increased the level of endothelial nitric oxide synthase (eNOS), as well as through upregulated phosphorylation of signal transducer and activator of transcription 1 and 3 and downregulated phosphorylated protein kinase B/phosphorylated phosphatidylinositol 3-kinase sign...
Source: Clinical Science - Category: Biomedical Science Authors: Tags: PublishAheadOfPrint Source Type: research